Literature DB >> 3739873

[Forced mid-expiratory flow rate (FEF 25-75%): a critical analysis of its value in recognizing diseases of the small airways].

M Terra Filho, F S Vargas, A Cukier, E Fiss, M Romeiro Neto, J Croce.   

Abstract

A total of 245 patients submitted to lung function test were studied. They were divided in 2 groups: A--FEV1.0/FVC greater than or equal to 75% and B--FEF25-75% less than 75%. These groups were further subdivided according to the age of the patients--subgroup 1 less than or equal to 50 years and subgroup 2 greater than 50 years. Patients with restrictive disorders were not included. The spirometric equipment employed was Hewlett-Packard Inc. Pulmonary Function Analyzer 47402-A. The results were obtained through a digital system and calculated from a graph impressed in a xy register. Results were automatically corrected to BTPS. In each group FVC and FEV1.0 were normal. In group A FVC and FEV1.0 were, respectively: A1-99.63 +/- 13.33 and 101.11 +/- 12.24, A2-97.60 +/- 11.06 and 98.81 +/- 12.18, expressed as percentage of predicted values. In group B the results were: B1-97.61 +/- 13.55% and 81.71 +/- 14.44%; B2-100.28 +/- 13.98% and 83.10 +/- 16.42%. The differences were not statistically significant at 5%. In subgroup A1 X FEV1.0/CVF was 83.41 +/- 5.63% and in subgroup A2, 79.42 +/- 4.23%. Maximum mid-expiratory flow rate was 88.64 +/- 24.39% in subgroup A1 and 65.26 +/- 17.88% in subgroup A2. These differences were statistically significant at 1%. In group B, FEV1.0/FVC was always less than 75%. In subgroup B1 it was 68.24 +/- 10.43% and in B2, 64.90 +/- 10.43% and values for FEF25-75% were 48.13 +/- 16.48% and 42.79 +/- 17.68%, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1986        PMID: 3739873

Source DB:  PubMed          Journal:  Allergol Immunopathol (Madr)        ISSN: 0301-0546            Impact factor:   1.667


  5 in total

1.  Obesity and its correlation with spirometric variables in patients with asthma.

Authors:  Alaa E Ghabashi; Mobeen Iqbal
Journal:  MedGenMed       Date:  2006-03-01

2.  Use of FEF25-75% to Guide IgG Dosing to Protect Pulmonary Function in CVID.

Authors:  Tracy Hwangpo; Zhixin Wang; Jack Ghably; Surya P Bhatt; Xiangqin Cui; Harry W Schroeder
Journal:  J Clin Immunol       Date:  2020-01-03       Impact factor: 8.317

3.  Clinical Implications of Having Reduced Mid Forced Expiratory Flow Rates (FEF25-75), Independently of FEV1, in Adult Patients with Asthma.

Authors:  Craig M Riley; Sally E Wenzel; Mario Castro; Serpil C Erzurum; Kian Fan Chung; Anne M Fitzpatrick; Benjamin Gaston; Elliot Israel; Wendy C Moore; Eugene R Bleecker; William J Calhoun; Nizar N Jarjour; William W Busse; Stephen P Peters; W Gerald Teague; Ronald Sorkness; Fernando Holguin
Journal:  PLoS One       Date:  2015-12-30       Impact factor: 3.240

4.  Predictive Markers of Bronchial Hyperreactivity in a Large Cohort of Young Adults With Cough Variant Asthma.

Authors:  Mario Malerba; Beatrice Ragnoli; Danila Azzolina; Paolo Montuschi; Alessandro Radaeli
Journal:  Front Pharmacol       Date:  2021-04-19       Impact factor: 5.810

5.  Correlation between Reduced FEF25-75% and a Positive Methacholine Challenge Test in Adults with Nonobstructive Baseline Spirometry.

Authors:  Irfan Shafiq; Mateen Haider Uzbeck; Zaid Zoumot; Mohamed Abuzakouk; Niyas Parappurath; Ali Saeed Wahla
Journal:  Pulm Med       Date:  2021-12-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.